TWST - Twist Bioscience Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
215,790
203,565
132,333
90,100
54,385
Cost of revenue
121,716
119,330
80,620
61,406
47,426
Gross profit
94,074
84,235
51,713
28,694
6,959
Operating expenses
Research development
128,919
120,307
69,072
43,006
35,683
Selling general and administrative
204,175
212,949
135,901
103,267
80,126
Total operating expenses
333,094
333,256
204,973
146,273
115,809
Operating income or loss
-239,020
-249,021
-153,260
-117,579
-108,850
Interest expense
55
80
367
787
1,294
Total other income/expenses net
19,073
17,765
-836
-22,682
-265
Income before tax
-214,054
-228,274
-154,028
-139,549
-107,377
Income tax expense
70
-10,411
-1,930
382
292
Income from continuing operations
-214,124
-217,863
-152,098
-139,931
-107,669
Net income
-214,124
-217,863
-152,098
-139,931
-107,669
Net income available to common shareholders
-214,124
-217,863
-152,098
-139,931
-107,669
Basic EPS
-
-4.04
-3.15
-3.57
-3.92
Diluted EPS
-
-4.04
-3.15
-3.57
-3.92
Basic average shares
-
53,885
48,251
39,190
27,462
Diluted average shares
-
53,885
48,251
39,190
27,462
EBITDA
-
-228,194
-153,661
-138,762
-106,083